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1. INTRODUCTION 
Thyroid hormones are known to affect the sensi- 
tivity of many tissues to a variety of hormones in- 
cluding adrenergic agents (review [ 11). In liver cells 
from normal rats, the metabolic actions of epi- 
nephrine are mediated through cui-adrenoceptors 
whereas in hepatoc~es from hypothyroid rats both 
cyl- and,&adrenoceptors seem to be involved [2-51. 
The increased ,&-adrenergic responsiveness eems 
to be due to an increased number of P-adrenocep- 
tors [4]. The effects of thyroid status on hepatic 
cui-adrenergic sensitivity are not as clear. Some 
authors [2,5] have found a marked decrease in 
at-adrenergic sensitivity in hepatocytes from hypo- 
thyroid rats, whereas others have found no change 
[3,4]. An imparied responsiveness to vasopressin 
and angiotensin II in hepatocytes from hypothy- 
roid rats was reported in [6]. This finding is of 
special interest since these vasopressor peptides 
seem to share with ml-adrenergic amines a cyclic 
AMP-independent calcium-signalling mechanism 
which is associated with phosphatidylinositol turn- 
over [7,8). Therefore, unless the loss of sensitivity 
to these peptides is due to a decreased number of 
receptors, a general oss of sensitivity for vasopres- 
sin, angiotensin II and al-adrenergic amines in the 
hypothyroid state would be expected. 
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Here, the ability of epinephrine, vasopressin and 
angiotensin II to stimulate glycogenolysis and 
phosphatidylinositol {PI) labeling in hepatocytes 
from normal and hypothyroid rats was studied. 
The calcium ionophore A23187 was employed to 
bypass the transduction mechanisms for calcium- 
signaliing. 
Our data show that hypothyroidism results in a 
marked insensitivity of rat hepatocytes to calcium; 
i.e., decreased sensitivity to vasopressin, angio- 
tensin II and A23187. The cYi-adrenergic effect of 
epinephrine was not markedly affected, which 
suggests that other factors besides calcium are 
probably involved in cui-adrenergic actions. 
2. MATERIALS AND METHODS 
6-n-Propyl 2-thiouracil, glucose oxidase, I-epi- 
nephrine, 1 -propranolol, arginine-vasopressin 
and angiotensin II were obtained from Sigma 
Chemicals. Collagenase and bovine serum albumin 
(fraction V) were obtained from Worthington and 
Reheis, respectively. Prazosin was a generous gift 
from Pfizer. “Pi (carrier free) was obtained from 
New England Nuclear. 
Female Wistar rats (-200 g) were used. Control 
and experimental animals were littermates, of 
approximately the same weight, and both were fed 
ad libitum with Purina rat chow. Hypothyroidism 
was induced by giving the rats water containing 
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0.015Yo 6-~-propyl-2-thiouracil for 23-40 days. 
Hypothyroidism was assessed by decreased weight 
gain, dryness of fur and markedly decreased blood 
levels of triiodcthyronine. 
Hepatocytes were isolated between 8 :00 and 
9:00 a.m. by the Berry and Friend method 191 as 
modified 171. Isolation, washing and incubation of 
the cells was done with Krebs-Ringer bicarbonate 
buffer, saturated with OZ/COZ (95%/5%) pH 7.4 
at 37°C. 
To determine the rate of glycogenolysis, cells 
were incubated for 60 min in the presence of the 
agents to be tested. The incubation was ended by 
cooling the cell suspensions in iced water. After 
1 min centrifugation at top speed in a clinical cen- 
trifuge, the concentration of glucose in the super- 
natant was measured by the glucose oxidase pro- 
cedure [lo]. For the study of PI labeling, cells were 
incubated for 60 min in the presence of 10 &i/ml 
32Pi. Cell lipids were extracted with chloro- 
form : methanol (2 : 1) and phospholipids were 
separated by one-dimensional thin-layer chromato- 
graphy [ 111. Radioactivity was counted in silica-gel 
scrappings of the phospholipids. 
EUTHYROID HYPOTHYROID 
Fig. 1. Stimulation of glycogenolysis by vasopressin, 
angiotensin II, A23 187 and adrenergic agents in hepato- 
cytes from euthyroid (A) and hypothyroid (B) rats. Cells 
were incubated under the conditions in section 2 and in 
the presence of the agents indicated on each bar, at: 
low5 M epinephrine (EPI): lo-’ M propranolol (PROP); 
10e5 M prazosin (PRAZ); 10v7 M vasopressin (VASO); 
10m5 M angiotensin II (ANGIO); 10e5 M A23187. Bars 
are means (+SEM) of duplicate incubations from 3 cell 
preparations. Results are expressed as percentage of 
control (C) glucose output which was 67 F 9 and 
57 * 5 nmol/mg cell wet wt for cells from euthyroid and 
hypothyroid rats, respectively. 
3. RESULTS AND DISCUSSION 
The stimulation of glycogenolysis by maximal 
concentrations of epinephrine, vasopressin angio- 
tensin II and the ionophore A23187 in euthyroid 
and hypothyroid rats is presented in fig. 1. All the 
effects were dose-dependent; the dose-response 
curves have been ommitted for clarity. In euthy- 
roid rats the effect of epinephrine was slightly 
diminished by the fl-adrenergic antagonist pro- 
pranolol, and was strongly diminished by the 
ml-adrenergic antagonist prazosin. This indicates 
the predominant role of q-adrenoceptors in 
mediating the glycogenolytic response to epi- 
nephrine. Propranolol (10e5 M) and prazosin 
(lo-’ M) were without effect on basal glycogenoly- 
sis (not shown). Vasopressin and angiotensin II, 
which seem to share the signal transduction system 
of al-adrenoceptors [7,8], strongly stimulated glu- 
cose output in hepatocytes from normal animals. 
In cells from hypothyroid rats, the stimulation 
of glycogenolysis produced by epinephrine was 
stronger than in hepatocytes from normal animals. 
This stimulation was diminished to a similar extent 
by propranolol and by prazosin; the residual effect 
observed in the presence of either antagonist was 
significantly diminished when both antagonists 
Table 1 
Effect of vasopressin, angiotensin II and epinephrine on 
the incorporation of radioactive phosphate into phos- 
phatidylinositol (PI) in hepatocytes from euthyroid and 
hypothyroid rats 
Additions Phosphatidylinositol labeling 
(To control) 
None 
Epinephrine lo-’ M 
Epinephrine 1O-5 M + 
Euthyroid Hypothyroid 
100 100 
291 f 28 491 f 28 
prazosin lo-’ M 115 f 15 131 + 16 
Vasopressin lo-’ M 442 zk 29 502 + 36 
Angiotensin II IO-’ M 335 * 33 279 f 23 
Cells were incubated under the conditions in section 2. 
Results are expressed as percentage of incorporation in 
the absence of hormones, and are the means (+SEM) of 
duplicate incubations from 3 cell preparations. Basal 
incorporation of label into phosphatidyIinosito1 was 
1549O+3530and15770rl:37OOcpm/1OOmgcellwet.wt 
in cells from euthyroid and hypothyroid rats, respectively 
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were present simultaneously. The adrenergic anta- 
gonists were without effect on basal glycogenolysis. 
This indicates that the glycogenolytic response to 
epinephrine in the hypothyroid state is a mixed cyr- 
and &effect with strong contribution from both 
receptor types. The stimulation of glycogenolysis 
through activation of al-adrenoceptors (epi- 
nephrine + propranolol) was remarkably similar in 
cells from control animals (154 + 6% of control) 
to the stimulation produced in hepatocytes from 
hypothyroid rats (159 f: 7% of control) (fig. 1). 
Surprisingly, in cells from hypothyroid rats, neither 
vasopressin or angiotensin II were able to stimu- 
late glycogenolysis (at any of the concentrations 
tested). Consistent with these findings we observed 
that vasopressin and angiotensin II did not stimu- 
late gluconeogenesis or ureogenesis in hepatocytes 
from hypothyroid animals whereas cul-adrenergic 
activation clearly stimulated these metabolic para- 
meters in these cells (in preparation). A possible 
explanation for this hyposensitivity to the vaso- 
pressor peptides could be the absence of their 
respective receptors. To test this possibility, stimu- 
lation of PI turnover by these agents was studied. 
Dose-response curves for the stimulation of PI 
turnover by these agents were nearly identical in 
hepatocytes from normal and hypothyroid rats. 
The effects of maximal doses of the hormones of 
this parameter in hepatocytes from normal and 
hypothyroid rats is presented in table 1. This effect 
of epinephrine was blocked by prazosin (table 1). 
These data indicate that cui-adrenoceptors, as well 
as the receptors for the vasopressor peptides, are 
present in the hypothyroid state, and are very 
probably coupled to their mechanism of signal 
transduction. Another possibility was that the sen- 
sibility of cells to the elevation in cytosol calcium 
brought about by these hormones could be altered 
in the hypothyroid state. The results obtained with 
ionophore A23 187 are shown in fig. 1. The iono- 
phore produced a strong glycogenolytic response in 
cells from euthyroid rats, whereas no response 
could be observed in cells from hypothyroid 
animals. 
Although this insensitivity to calcium could ex- 
plain the refractoriness of cells from hypothyroid 
rats to vasopressin and angiotensin II, it raises 
questions on the mechanism(s) involved in medi- 
ating crl-adrenergic action. The accumulation of 
cyclic AMP due to epinephrine in cells from both 
control and hypothyroid rats was completely 
blocked by propranolol, indicating that cyclic 
AMP is not mediating the Lur-adrenergic effects in 
any of the thyroid states (not shown). Thus, a 
CAMP-independent calcium-independent mechan- 
ism is operating to bring about the al-adrenergic 
actions, which is readily observed in the hypothy- 
roid state. The existence of at least two different 
transduction mechanisms for the al-adrenergic 
actions could also explain the different require- 
ments for extracellular calcium between vasopres- 
sin, angiotensin II and ai-adrenergic amines. The 
former two are strictly dependent on the presence 
of this ion whereas the latter is dependent o a 
much lesser extent. 
The insensitivity to calcium brought about by 
hypothyroidism reveals that factor(s) besides cal- 
cium probably mediate cl-adrenergic actions, and 
that such factors do not seem to be involved in the 
actions of the vasopressor peptides. 
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